Alnylam Pharmaceuticals, Inc.
US ˙ NasdaqGS ˙ US02043Q1076

SecurityALNY / Alnylam Pharmaceuticals, Inc.
InstitutionWolverine Trading, Llc
Latest Disclosed Ownership6,262 shares
Latest Disclosed Value $ 2,802,182
Wolverine Trading, Llc ownership in ALNY / Alnylam Pharmaceuticals, Inc.

On November 14, 2025 - Wolverine Trading, Llc filed a 13F-HR form disclosing ownership of 6,262 shares of Alnylam Pharmaceuticals, Inc. (US:ALNY) valued at $2,855,472 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 18, 2025 disclosing 1,122 shares of Alnylam Pharmaceuticals, Inc.. This represents a change in shares of 458.11% during the quarter. The current value of the position is $1,832,136 USD.

Wolverine Trading, Llc has a history of taking positions in derivatives of the underlying security (ALNY) in the form of stock options. The firm currently holds call options representing 29,300 of underlying shares valued at $13,111,457 USD and put options representing 16,200 of underlying shares valued at $7,249,338 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

ALNY / Alnylam Pharmaceuticals, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,262 5,140 458.11 2,802 674.03 0.0020
2025-08-18 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,122 -1,316 -53.98 362 -44.65 0.0004
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,438 -4,885 -66.71 655 -62.15 0.0008
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,323 7,323 1,728 0.0016
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -2,946 -100.00 0 -100.00
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,946 2,946 564 0.0006
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -1,323 -100.00 0 -100.00
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,323 1,323 314 0.0005
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -2,997 -100.00 0 -100.00
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,997 1,425 90.65 436 67.69 0.0007
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 1,572 -2,054 -56.65 260 -58.06 0.0003
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,626 1,482 69.12 620 63.16 0.0007
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 2,144 -4,622 -68.31 380 -66.13 0.0004
2021-08-06 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 6,766 2,394 54.76 1,122 89.85 0.0017
2021-05-14 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 4,372 962 28.21 591 32.21 0.0009
2021-02-12 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 3,410 3,410 447 0.0007
2020-05-11 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -5,440 -100.00 0 -100.00
2020-02-12 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 5,440 5,440 624 0.0015
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -7,356 -100.00 0 -100.00
2019-08-20 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 7,356 7,356 534 0.0015
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -13,618 -100.00 0 -100.00
2019-02-13 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 13,618 -12,860 -48.57 959 -58.61 0.0027
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 26,478 26,478 2,317 0.0051
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 0 -10,288 -100.00 0 -100.00
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM 02043Q107 10,288 10,288 1,307 0.0047
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 29,300 83.12 13,111 153.84 n/a n/a n/a
2025-08-18 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 16,000 -20.79 5,165 -4.74 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 20,200 83.64 5,423 108.86 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 11,000 -34.13 2,596 -43.44 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 16,700 -62.89 4,591 -58.02 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 45,000 103.62 10,935 231.16 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 22,100 90.52 3,303 48.74 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 11,600 46.84 2,220 58.68 n/a n/a n/a
2023-11-15 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 7,900 6.76 1,399 -0.99 n/a n/a n/a
2023-08-23 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 7,400 -10.84 1,414 141,200.00 n/a n/a n/a
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 8,300 -29.66 2 -99.96 n/a n/a n/a
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 11,800 20.41 2,804 36.65 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 9,800 19.51 2,052 72.00 n/a n/a n/a
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 8,200 -8.89 1,193 -19.77 n/a n/a n/a
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 9,000 21.62 1,487 17.46 n/a n/a n/a
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 7,400 60.87 1,266 55.15 n/a n/a n/a
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 4,600 -69.33 816 -67.20 n/a n/a n/a
2021-08-06 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 15,000 581.82 2,488 737.71 n/a n/a n/a
2021-05-14 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 2,200 -87.71 297 -87.34 n/a n/a n/a
2021-02-12 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 17,900 -25.42 2,346 -32.59 n/a n/a n/a
2020-11-13 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 24,000 -7.34 3,480 -9.16 n/a n/a n/a
2020-08-13 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 25,900 -4.78 3,831 29.43 n/a n/a n/a
2020-05-11 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 27,200 -49.82 2,960 -52.38 n/a n/a n/a
2020-02-12 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 54,200 22.35 6,216 73.00 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 44,300 28.41 3,593 43.55 n/a n/a n/a
2019-08-20 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 34,500 -11.99 2,503 -31.67 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 39,200 -13.27 3,663 15.12 n/a n/a n/a
2019-02-13 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 45,200 -17.52 3,182 -33.65 n/a n/a n/a
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Call 54,800 -25.75 4,796 -45.44 n/a n/a n/a
2018-08-13 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Call 73,800 0.00 8,790 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Call 73,800 33.94 8,790 25.57 n/a n/a n/a
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Call 55,100 7,000 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-11-14 2025-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 16,200 4.52 7,249 44.89 n/a n/a n/a
2025-08-18 2025-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 15,500 22.05 5,004 46.76 n/a n/a n/a
2025-05-15 2025-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 12,700 2.42 3,409 16.51 n/a n/a n/a
2025-02-14 2024-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 12,400 -52.85 2,927 -59.53 n/a n/a n/a
2024-11-14 2024-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 26,300 -30.97 7,230 -21.91 n/a n/a n/a
2024-08-14 2024-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 38,100 59.41 9,258 159.26 n/a n/a n/a
2024-05-15 2024-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 23,900 58.28 3,572 23.56 n/a n/a n/a
2024-02-14 2023-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 15,100 37.27 2,890 48.36 n/a n/a n/a
2023-11-15 2023-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 11,000 48.65 1,948 37.86 n/a n/a n/a
2023-08-23 2023-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 7,400 -28.16 1,414 70,550.00 n/a n/a n/a
2023-05-15 2023-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 10,300 87.27 2 -99.85 n/a n/a n/a
2023-02-14 2022-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 5,500 -11.29 1,307 0.69 n/a n/a n/a
2022-11-14 2022-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 6,200 -47.01 1,298 -23.74 n/a n/a n/a
2022-08-15 2022-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 11,700 39.29 1,702 22.62 n/a n/a n/a
2022-05-16 2022-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 8,400 -34.38 1,388 -36.59 n/a n/a n/a
2022-02-14 2021-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 12,800 103.17 2,189 95.80 n/a n/a n/a
2021-11-12 2021-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 6,300 -76.23 1,118 -74.57 n/a n/a n/a
2021-08-06 2021-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 26,500 204.60 4,396 273.81 n/a n/a n/a
2021-05-14 2021-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 8,700 -28.10 1,176 -25.85 n/a n/a n/a
2021-02-12 2020-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 12,100 -32.78 1,586 -39.23 n/a n/a n/a
2020-11-13 2020-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 18,000 -11.76 2,610 -13.49 n/a n/a n/a
2020-08-13 2020-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 20,400 -10.13 3,017 22.15 n/a n/a n/a
2020-05-11 2020-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 22,700 -31.00 2,470 -34.53 n/a n/a n/a
2020-02-12 2019-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 32,900 6.47 3,773 50.56 n/a n/a n/a
2019-11-14 2019-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 30,900 -5.79 2,506 5.29 n/a n/a n/a
2019-08-20 2019-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 32,800 -9.64 2,380 -29.83 n/a n/a n/a
2019-05-15 2019-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 36,300 -26.22 3,392 -2.08 n/a n/a n/a
2019-02-13 2018-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 49,200 -29.91 3,464 -43.62 n/a n/a n/a
2018-11-14 2018-09-30 13F ALNYLAM PHARMACEUTICALS COM Put 70,200 55.65 6,144 14.39 n/a n/a n/a
2018-08-13 2018-06-30 13F ALNYLAM PHARMACEUTICALS COM Put 45,100 0.00 5,371 0.00 n/a n/a n/a
2018-05-15 2018-03-31 13F ALNYLAM PHARMACEUTICALS COM Put 45,100 -19.75 5,371 -24.78 n/a n/a n/a
2018-02-14 2017-12-31 13F ALNYLAM PHARMACEUTICALS COM Put 56,200 7,140 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.